PacBio Developing Chip Technology for Highly Multiplexed 'V2' Sequencers; Launch Planned for 2014
February 23, 2010
PacBio Developing Chip Technology for Highly Multiplexed 'V2' Sequencers; Launch Planned for 2014
Starting in 2014, PacBio plans to launch two FDA-certified systems that are based on the new technology: a high-throughput instrument that will be able to sequence a human genome with several-fold coverage in 15 minutes or less; and a sub-$50,000 point-of-care instrument that will be "the size of a copier" and have a lower throughput.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Launch of PacBio RS Drives Q2 Revenue, but Investors Raise Concerns Over Pace of Uptake
August 9, 2011 / In Sequence - PacBio Ships First Two Commercial Systems; Order Backlog Grows to 44
May 3, 2011 / In Sequence - PacBio Grows Order Backlog in Q4; Sees Increased Interest in Microbial Sequencing
February 22, 2011 / In Sequence - USPTO Board Rules on PacBio, Life Tech Patent Interference Case
February 1, 2011 / In Sequence - PacBio Reveals Beta System Specs for RS; Says Commercial Release is on Track for First Half of 2011
December 7, 2010 / In Sequence